Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 19,882 |
|
|||||
| News | - | ||||||
| Day High | 10.80 | Low High |
|||||
| Day Low | 10.5754 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Curis Inc | CRIS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0386 | -0.36% | 10.7564 | 13:04:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 10.79 | 10.5754 | 10.80 | 10.795 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 82 | 19,882 | $ 10.80 | $ 214,674 | - | 3.80 - 18.526 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:54:27 | 194 | $ 10.7564 | USD |
Curis Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 63.54M | 5.89M | - | 10.02M | -47.41M | -8.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Curis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRIS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.34 | 15.745 | 9.50 | 11.79 | 46,942 | -4.58 | -29.88% |
| 1 Month | 15.12 | 16.99 | 9.50 | 13.68 | 22,117 | -4.36 | -28.86% |
| 3 Months | 10.14 | 17.49 | 9.39 | 13.51 | 27,536 | 0.6164 | 6.08% |
| 6 Months | 9.03 | 17.49 | 7.85 | 12.10 | 45,159 | 1.73 | 19.12% |
| 1 Year | 17.60 | 18.526 | 3.80 | 12.91 | 146,833 | -6.84 | -38.88% |
| 3 Years | 286.00 | 312.00 | 3.80 | 66.54 | 1,270,598 | -275.24 | -96.24% |
| 5 Years | 30.60 | 348.00 | 3.80 | 96.89 | 1,570,036 | -19.84 | -64.85% |
Curis Description
| Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. |
